MD Magazine |
FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
FDA.gov Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status. “Diagnostic results about a woman's menopausal status may prompt discussions about ... FDA Permits Marketing for Menopausal Status Diagnostic Test |
October 24, 2018 at 06:09PM | marketing - Google News
FDA permits marketing of a diagnostic test to aid in the determination of menopausal status - FDA.gov
marketing - Google News
Nenhum comentário:
Postar um comentário